Disease ID | Disease name | Source of annotation with CACNA1D | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
614896 | SINOATRIAL NODE DYSFUNCTION AND DEAFNESS | OMIM | link to OMIM | 1 | CACNA1D |
615474 | PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES | ClinVar, OMIM, HUMSAVAR | link to OMIM | 1 | CACNA1D |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
cGMP-PKG signaling pathway | hsa04022 | 5.32 |
Calcium signaling pathway | hsa04020 | 5.22 |
cAMP signaling pathway | hsa04024 | 5.05 |
Retrograde endocannabinoid signaling | hsa04723 | 6.03 |
Cholinergic synapse | hsa04725 | 5.88 |
Glutamatergic synapse | hsa04724 | 5.84 |
GABAergic synapse | hsa04727 | 6.24 |
Serotonergic synapse | hsa04726 | 5.84 |
Hypertrophic cardiomyopathy (HCM) | hsa05410 | 6.21 |
Dopaminergic synapse | hsa04728 | 5.69 |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) | hsa05412 | 6.32 |
Dilated cardiomyopathy | hsa05414 | 6.08 |
Oxytocin signaling pathway | hsa04921 | 5.4 |
Vascular smooth muscle contraction | hsa04270 | 5.74 |
GnRH signaling pathway | hsa04912 | 6.18 |
Insulin secretion | hsa04911 | 6.18 |
MAPK signaling pathway | hsa04010 | 4.63 |
Circadian entrainment | hsa04713 | 6.11 |
Type II diabetes mellitus | hsa04930 | 7.12 |
Carbohydrate digestion and absorption | hsa04973 | 7.28 |
Cardiac muscle contraction | hsa04260 | 6.34 |
Amphetamine addiction | hsa05031 | 6.62 |
Alzheimer's disease | hsa05010 | 5.34 |
Adrenergic signaling in cardiomyocytes | hsa04261 | 5.44 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Regulation of insulin secretion | R-HSA-422356 | 6.66 |
Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.18 |
Integration of energy metabolism | R-HSA-163685 | 6.24 |
NCAM signaling for neurite out-growth | R-HSA-375165 | 4.9 |
NCAM1 interactions | R-HSA-419037 | 7.59 |
Metabolism | R-HSA-1430728 | 2.34 |
Axon guidance | R-HSA-422475 | 3.93 |
Developmental Biology | R-HSA-1266738 | 3.48 |
GO term | GO ID | GO IC |
---|---|---|
cation channel activity | GO:0005261 | 4.04 |
calcium channel activity | GO:0005262 | 5.03 |
high voltage-gated calcium channel activity | GO:0008331 | 7.34 |
binding | GO:0005488 | 0.18 |
ion binding | GO:0043167 | 1.36 |
ankyrin binding | GO:0030506 | 6.74 |
calcium ion transmembrane transporter activity | GO:0015085 | 4.89 |
voltage-gated calcium channel activity involved in cardiac muscle cell action potential | GO:0086007 | 8.13 |
divalent inorganic cation transmembrane transporter activity | GO:0072509 | 4.62 |
voltage-gated cation channel activity | GO:0022843 | 4.83 |
passive transmembrane transporter activity | GO:0022803 | 3.6 |
metal ion transmembrane transporter activity | GO:0046873 | 3.71 |
metal ion binding | GO:0046872 | 1.41 |
alpha-actinin binding | GO:0051393 | 6.6 |
cation binding | GO:0043169 | 1.4 |
transporter activity | GO:0005215 | 2.57 |
ion channel activity | GO:0005216 | 3.71 |
cation transmembrane transporter activity | GO:0008324 | 3.32 |
substrate-specific transporter activity | GO:0022892 | 2.72 |
actinin binding | GO:0042805 | 6.3 |
voltage-gated calcium channel activity involved SA node cell action potential | GO:0086059 | 9.05 |
substrate-specific transmembrane transporter activity | GO:0022891 | 2.9 |
inorganic cation transmembrane transporter activity | GO:0022890 | 3.49 |
substrate-specific channel activity | GO:0022838 | 3.67 |
cytoskeletal protein binding | GO:0008092 | 3.02 |
ion transmembrane transporter activity | GO:0015075 | 3.04 |
voltage-gated channel activity | GO:0022832 | 4.49 |
transmembrane transporter activity | GO:0022857 | 2.82 |
channel activity | GO:0015267 | 3.6 |
gated channel activity | GO:0022836 | 3.96 |
protein binding | GO:0005515 | 0.46 |
voltage-gated calcium channel activity | GO:0005245 | 6.0 |
voltage-gated ion channel activity | GO:0005244 | 4.49 |